"McDonough District Hospital has been a source of healing, caring, and hope since we first opened our doors to the people of western Illinois in 1958. Through the years, we have continually expanded our high quality services for people at all stages of their lives. Today, MDH is a 48-bed health care facility providing an impressive spectrum of advanced medical treatments and personalized health services. While our services have advanced, our commitment to providing health care in an atmosphere of compassion and caring has remained constant. Our providers, nurses, and staff offer patients and their families continuity of care while remaining close to home - making McDonough District Hospital our communities' first choice in healthcare."

During the past decade, McDonough District Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 130 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 26 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "McDonough District Hospital" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 77 trials, followed by "National Cancer Institute (NCI)" with 61 trials sponsored, "SWOG Cancer Research Network" with 15 trials sponsored, "Eastern Cooperative Oncology Group" with 14 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 14 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "McDonough District Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 136 trials as a collaborator, "NCIC Clinical Trials Group" with 14 trials as a collaborator, "Cancer and Leukemia Group B" with 12 trials as a collaborator, "Eastern Cooperative Oncology Group" with 11 trials as a collaborator and "NRG Oncology" with 11 trials as a collaborator. Other collaborators include 31 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "McDonough District Hospital" are "Breast Cancer" (30 trials), "Lung Cancer" (18 trials), "Lymphoma" (17 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (11 trials) and "Leukemia" (9 trials). Many other conditions were trialed in "McDonough District Hospital" in a lesser frequency.

Most popular intervention types in "McDonough District Hospital" are "Drug" (168 trials), "Biological" (80 trials), "Other" (80 trials), "Radiation" (34 trials) and "Procedure" (17 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (41 trials), "placebo" (23 trials), "Bevacizumab" (17 trials), "Paclitaxel" (16 trials) and "carboplatin" (16 trials). Other intervention names were less common.

The vast majority of trials in "McDonough District Hospital" are 155 trials for "All" genders, 36 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "McDonough District Hospital". undefined are not yet recruiting, undefined are recruiting, 40 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 140 completed trials in McDonough District Hospital, undefined suspended trials, and 14 terminated clinical trials to date.

Out of the total trials that were conducted in McDonough District Hospital, 12 "Phase 1" clinical trials were conducted, 93 "Phase 2" clinical trials and 93 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".